F-star Therapeutics Historical PE Ratio image   This FSTX PE ratio history page last updated 11/17/2022
F-star Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/10/2022
4.76-0.84-3.36NA
Q2 2022
8/11/2022
6.57-0.88-3.52NA
Q1 2022
5/10/2022
2.44-0.57-2.28NA
Q4 2021
3/14/2022
2.770.471.881.5
Q3 2021
11/10/2021
6.27-0.52-2.08NA
Q2 2021
8/12/2021
6.71-0.92-3.68NA
Q1 2021
5/17/2021
6.74-1.08-4.32NA
F-star Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/10/2022
4.76-0.84-1.82NA
Q2 2022
8/11/2022
6.57-0.88-1.50NA
Q1 2022
5/10/2022
2.44-0.57-1.54NA
Q4 2021
3/14/2022
2.770.47-2.05NA
Q3 2021
11/10/2021
6.27-0.52NANA
Q2 2021
8/12/2021
6.71-0.92NANA
Q1 2021
5/17/2021
6.74-1.08NANA
Quotes delayed 20 minutes

Email EnvelopeFree FSTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
F-star Therapeutics (FSTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

FULC PE Ratio History
FVE PE Ratio History
FWBI PE Ratio History
GALT PE Ratio History
GBIO PE Ratio History
GBT PE Ratio History
GEG PE Ratio History
GERN PE Ratio History
GH PE Ratio History
GILD PE Ratio History
How should the FSTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like F-star Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this FSTX Historical PE Ratio page.

What is the average historical PE for FSTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The FSTX historical PE ratio using the annualized quarterly earnings method works out to 1.5.

What is the average historical PE for FSTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The FSTX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the F-star Therapeutics Historical PE Ratio information for F-star Therapeutics' stock. The average FSTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average FSTX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this FSTX historical PE result, against the recent PE: when this page was posted on 11/16/2022, the most recent closing price for FSTX had been 4.61, and the most recent quarterly earnings result, annualized, was 1.88. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent FSTX PE on 11/16/2022 based on annualized quarterly EPS was 2.5. Based on FSTX's history, that recent PE is elevated relative to the historical average, with the recent PE 66.7% higher than the historical average PE across our data set for F-star Therapeutics.

For self directed investors doing their due diligence on FSTX or any other given stock, valuation analysis for FSTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate F-star Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for FSTX. Thanks for visiting, and the next time you need to research FSTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: DVMT YTD Return, Funds Holding CNM, IVV Average Annual Return.

 

F-star Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.